Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective

WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

A conversational artificial intelligence system enhances precision medicine and health equity

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration

Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer

Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal cancer shows positive results

Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer

ELCC 2025: Latest in EGFR positive NSCLC

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC